Omadacycline Is Highly Active In Vitro against Mycoplasma genitalium
ABSTRACT Here, we performed in vitro susceptibility testing on 10 Mycoplasma genitalium isolates against omadacycline, minocycline, tetracycline, doxycycline, moxifloxacin, levofloxacin, and azithromycin. Omadacycline was the most potent agent, with all MICs of ≤0.5 μg/mL. MICs were not affected by...
Main Authors: | Ken B. Waites, Donna M. Crabb, T. Prescott Atkinson, William M. Geisler, Li Xiao |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-12-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.03654-22 |
Similar Items
-
Trends of Mycoplasma genitalium infections in Berlin, Germany, 2017–2023
by: Roger Dumke, et al.
Published: (2025-03-01) -
Prevalence of Site-Specific Mycoplasma genitalium Infection and Macrolide and Fluoroquinolone-Associated Mutations in Men Who Have Sex with Men in Shenzhen, China
by: Leng X, et al.
Published: (2025-01-01) -
Macrolide and fluoroquinolone resistance in Mycoplasma genitalium isolated from pregnant women in Russia and Belarus
by: Avchinnikova D.A., et al.
Published: (2024-06-01) -
Detection and Prevalence of Macrolide and Fluoroquinolone Resistance in <i>Mycoplasma genitalium</i> in Badalona, Spain
by: Belén Rivaya, et al.
Published: (2022-04-01) -
High prevalence of resistance to macrolides and fluoroquinolones in Mycoplasma genitalium isolated from patients in two Russian megalopolises – Moscow and St. Petersburg in 2021– 2024
by: Edelstein I.A., et al.
Published: (2024-09-01)